Doseology Sciences Net Income
| DOSEF Stock | USD 0.52 0.00 0.00% |
As of the 19th of February, Doseology Sciences shows the Mean Deviation of 20.22, standard deviation of 75.44, and Variance of 5690.88. Doseology Sciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Doseology Sciences, which can be compared to its peers. Please confirm Doseology Sciences standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Doseology Sciences is priced favorably, providing market reflects its regular price of 0.52 per share. As Doseology Sciences is a penny stock we also recommend to verify its jensen alpha numbers.
Doseology Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Doseology Sciences' valuation are provided below:Doseology Sciences does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Doseology |
Doseology Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Doseology Sciences' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Doseology Sciences.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Doseology Sciences on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Doseology Sciences or generate 0.0% return on investment in Doseology Sciences over 90 days. Doseology Sciences is related to or competes with Ensysce Biosciences. Doseology Sciences Inc. engages in the cultivation and extraction of nutraceutical and pharmaceutical products in Canada More
Doseology Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Doseology Sciences' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Doseology Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1157 | |||
| Maximum Drawdown | 600.35 | |||
| Value At Risk | (1.89) | |||
| Potential Upside | 17.65 |
Doseology Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Doseology Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Doseology Sciences' standard deviation. In reality, there are many statistical measures that can use Doseology Sciences historical prices to predict the future Doseology Sciences' volatility.| Risk Adjusted Performance | 0.102 | |||
| Jensen Alpha | 9.13 | |||
| Total Risk Alpha | 5.27 | |||
| Treynor Ratio | (0.90) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Doseology Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Doseology Sciences February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.102 | |||
| Market Risk Adjusted Performance | (0.89) | |||
| Mean Deviation | 20.22 | |||
| Coefficient Of Variation | 859.38 | |||
| Standard Deviation | 75.44 | |||
| Variance | 5690.88 | |||
| Information Ratio | 0.1157 | |||
| Jensen Alpha | 9.13 | |||
| Total Risk Alpha | 5.27 | |||
| Treynor Ratio | (0.90) | |||
| Maximum Drawdown | 600.35 | |||
| Value At Risk | (1.89) | |||
| Potential Upside | 17.65 | |||
| Skewness | 7.37 | |||
| Kurtosis | 56.75 |
Doseology Sciences Backtested Returns
Doseology Sciences is out of control given 3 months investment horizon. Doseology Sciences secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12 % return per unit of risk over the last 3 months. We were able to analyze and collect data for nineteen different technical indicators, which can help you to evaluate if expected returns of 8.78% are justified by taking the suggested risk. Use Doseology Sciences Standard Deviation of 75.44, mean deviation of 20.22, and Variance of 5690.88 to evaluate company specific risk that cannot be diversified away. Doseology Sciences holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -9.75, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Doseology Sciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Doseology Sciences is expected to outperform it. Use Doseology Sciences potential upside, as well as the relationship between the rate of daily change and relative strength index , to analyze future returns on Doseology Sciences.
Auto-correlation | -0.55 |
Good reverse predictability
Doseology Sciences has good reverse predictability. Overlapping area represents the amount of predictability between Doseology Sciences time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Doseology Sciences price movement. The serial correlation of -0.55 indicates that about 55.0% of current Doseology Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Doseology Sciences reported net income of (1.94 Million). This is 100.57% lower than that of the Healthcare sector and 102.77% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.34% higher than that of the company.
Doseology Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Doseology Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Doseology Sciences could also be used in its relative valuation, which is a method of valuing Doseology Sciences by comparing valuation metrics of similar companies.Doseology Sciences is currently under evaluation in net income category among its peers.
Doseology Fundamentals
| Current Valuation | 430.56 K | |||
| Shares Outstanding | 41.1 M | |||
| Shares Owned By Insiders | 17.78 % | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 61.66 X | |||
| Revenue | 16.05 K | |||
| EBITDA | (1.72 M) | |||
| Net Income | (1.94 M) | |||
| Cash Flow From Operations | (1.71 M) | |||
| Market Capitalization | 4.11 M | |||
| Total Asset | 3.87 M | |||
| Net Asset | 3.87 M |
About Doseology Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Doseology Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Doseology Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Doseology Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Doseology OTC Stock
Doseology Sciences financial ratios help investors to determine whether Doseology OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Doseology with respect to the benefits of owning Doseology Sciences security.